Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: MELAS syndrome is a rare, progressive multisystem mitochondrial disorder characterized by mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. It primarily affects high-energy organs like the brain and muscles, leading to a spectrum of neurological and physical symptoms that typically manifest in childhood or early adulthood. What exactly is MELAS syndrome? MELAS syndrome stands for Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes.
1 people with MELAS Syndrome have shared their first-person experience on this question at DiseaseMaps.
TL;DR: MELAS syndrome is a rare, progressive multisystem mitochondrial disorder characterized by mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. It primarily affects high-energy organs like the brain and muscles, leading to a spectrum of neurological and physical symptoms that typically manifest in childhood or early adulthood.
MELAS syndrome stands for Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes. It is a rare genetic condition that falls under the umbrella of mitochondrial diseases. Because mitochondria act as the "power plants" of our cells, MELAS syndrome disrupts the body’s ability to generate the energy required for cells to function correctly. This leads to systemic issues, most notably affecting the central nervous system and skeletal muscles, which have the highest energy demands in the human body.
Because mitochondria are present in nearly every cell, MELAS syndrome can impact multiple body systems. The primary clinical features include:
MELAS syndrome is considered a rare disease, though exact prevalence data remains challenging to determine due to underdiagnosis. Current estimates suggest the prevalence of mitochondrial diseases as a group is approximately 1 in 5,000 individuals, with MELAS syndrome being one of the more recognized forms. It typically presents in childhood, adolescence, or early adulthood, though onset can occur at any age. There is no known gender or geographic preference; however, it is passed down through maternal inheritance, meaning it is transmitted from a mother to all of her children through mitochondrial DNA.
The underlying mechanism of MELAS syndrome involves mutations in the mitochondrial DNA (mtDNA). The most common mutation is in the MT-TL1 gene, which encodes a transfer RNA molecule. When this process is impaired, the mitochondria cannot produce the proteins necessary for the respiratory chain, leading to decreased ATP (cellular energy) production. This energy deficit causes the "stroke-like" episodes that differentiate MELAS syndrome from typical ischemic strokes, as the neurological damage in this condition is often not restricted to the territory of a single blood vessel.
While many mitochondrial diseases share overlapping features, MELAS syndrome is clinically distinct due to the specific combination of stroke-like episodes and elevated lactate levels. Unlike other conditions like Leber Hereditary Optic Neuropathy (which primarily affects vision) or Kearns-Sayre syndrome (which often involves eye muscle paralysis and heart block), the hallmark of MELAS syndrome is the acute, recurring neurological crisis that mimics a stroke.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of a qualified healthcare professional regarding any medical condition.